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Background: Aphasia is a severely disabling condition occurring in 20 to 25% of stroke patients. Most patients with
aphasia due to stroke receive speech and language therapy. Methodologically sound randomised controlled trials
investigating the effect of specific interventions for patients with aphasia following stroke are scarce. The currently
available evidence suggests that intensive speech and language therapy is beneficial for restoration of
communication, but the optimal timing of treatment is as yet unclear.
In the Rotterdam Aphasia Therapy Study-3 we aim to test the hypothesis that patients with aphasia due to stroke
benefit more from early intensive cognitive-linguistic therapy than from deferred regular language therapy.
Methods/design: In a single blinded, multicentre, randomised controlled trial, 150 patients with first ever aphasia
due to stroke will be randomised within two weeks after stroke to either early intensive cognitive-linguistic therapy
(Group A) or deferred regular therapy (Group B). Group A will start as soon as possible, at the latest two weeks after
stroke, with a four week period of one hour a day treatment with cognitive-linguistic therapy. In Group B
professional speech and language therapy is deferred for four weeks. After this period, patients will follow the
conventional procedure of speech and language therapy. Participants will be tested with an extensive linguistic test
battery at four weeks, three months and six months after inclusion. Primary outcome measure is the difference in
score between the two treatment groups on the Amsterdam-Nijmegen Everyday Language Test, a measure of
everyday verbal communication, four weeks after randomisation.
Trial registration: This trial is registered in the Dutch Trial Register (www.trialregister.nl), NTR3271.
Keywords: Aphasia, Stroke, Cognitive-linguistic therapy, Treatment, Timing, Intensity, RCTBackground
About one fifth to a quarter of all stroke patients suffer
from aphasia [1]. Aphasia after stroke is a major health
problem with dramatic consequences for the quality of
life of affected individuals. Communication is essential
in daily life and may influence the outcome of rehabilita-
tion [2], since different forms of therapy are usually
instructed verbally. Hence, speech and language therapy* Correspondence: f.nouwens@erasmusmc.nl
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reproduction in any medium, provided the or(SLT) is considered very important in the acute phase
after stroke.
The effectiveness of SLT has been evaluated in a variety
of studies, many of which relied on small samples and
were of limited methodological quality. Recently the
Cochrane Collaboration has published a review of 39 trials
on the efficacy of language therapy for aphasia after stroke
[3]. The authors conclude that there is some evidence that
SLT is more effective than no SLT for recovery of commu-
nication after stroke and that efficacy of SLT seems to be
influenced by intensity of therapy. However, they empha-
sise that these results should be interpreted cautiously, asral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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across studies is hampered by a large degree of heterogen-
eity regarding characteristics of the study population, ap-
plied treatment methods, timing and duration of therapy,
and outcome assessments.
There are two main approaches in aphasia treatment:
cognitive-linguistic therapy (CLT) and communicative or
functional therapy [4]. CLT focuses on deficits in linguistic
components, such as semantics (word meaning), phon-
ology (speech sounds) and syntax (sentence level), and
aims at restoring linguistic processes that are the founda-
tion of language. Communicative therapy focuses on com-
pensation by making use of all communicative channels;
patients learn to utilise preserved verbal as well as nonver-
bal communicative functions. Communicative therapy is
provided in a realistic everyday environment and uses ges-
tures, communication aids, such as an icon board, role
plays and the Promoting Aphasics’ Communicative Effect-
iveness (PACE) method [5]. CLT is mostly applied in early
stages after stroke and communicative therapy later on.
Our group previously studied the efficacy of CLT, aimed
at semantic and phonological processing, in comparison
to communicative therapy in the acute stage of aphasia in
the Rotterdam Aphasia Therapy Study (RATS) – 2 [6]. A
total of 80 aphasic patients were randomised to either
CLT or communicative therapy for six months, starting
within three weeks after the stroke. We found no signifi-
cant difference between groups on the primary outcome
measure, the Amsterdam-Nijmegen Everyday Language
Test, A-scale (ANELT-A) [7]. However, the majority of the
secondary outcome measures on semantics and phonology
were in favour of CLT. Perhaps the treatment intensity of
both interventions, on average 2.1 hours per week, was in-
sufficient to generate a significant treatment effect on top
of spontaneous recovery [8-10].
Recovery of communication usually occurs shortly after
stroke [11-14]. Most likely restoration of the perilesional
network in the left hemisphere is the primary mechanism
underlying this spontaneous recovery [15]. Therapeutic
strategies to restore cerebral blood flow, such as thromb-
olysis, enhance spontaneous recovery. SLT is aimed at
stimulating cortical networks involved in language, hence
increasing blood flow to these damaged areas. CLT espe-
cially stimulates the linguistic cortical network through
specific exercises for linguistic components, such as
semantics, phonology and syntax [4]. Hence SLT, and in
particular CLT, is thought to contribute positively to spon-
taneous recovery of language [14,15]. Some, therefore,
claim that the focus of SL-therapists in the acute stage of
aphasia, when restoration of the linguistic network is still
plausible, should be on CLT [14,16].
In this respect, several clinical studies suggest that ther-
apy provided immediately after stroke results in more
beneficial effects than deferred treatment [11]. In a reviewarticle that was not restricted to randomised trials but also
included studies with other designs, the authors conclude
that SLT in the acute stages of aphasia following stroke is
almost twice as effective as natural recovery alone [10].
This assumes the presence of a “critical period” after
stroke during which the brain is more susceptible to re-
habilitation. Furthermore, it implies that SLT should be
initiated as soon as possible after stroke. This assumption
also suggests that if SLT is initiated too late, recovery
might be restricted. The length of this supposed “critical
period”, however, is unclear and optimal timing of therapy
remains uncertain.
A second mechanism of recovery is neural plasticity [17].
Intensive training, for instance, massed practise, is thought
to trigger remodelling and consolidation of neural net-
works [15]. Efficacy of SLT is considered to be related to
intensity [8]. In the Cochrane systematic review of rando-
mised controlled trials on SLT for aphasic stroke patients,
it was shown that efficacy of SLT positively correlated with
treatment intensity, although this was related to more
therapy drop-outs [3]. However, a recently published pilot
study on intensive SLT in 59 acute stroke patients with
aphasia suggests that early intensive SLT is feasible in the
acute stage after stroke [18]. The number of drop-outs or
deaths reported in the intervention group with daily ther-
apy was not higher than in the control group with usual
care therapy.
Another trial, in which 123 aphasic patients were ran-
domised for intensive SLT (three weeks of daily SLT for
45 minutes on workdays, starting within two days after
stroke) or control condition (no SLT for three weeks) in
the acute stage of aphasia, showed no significant differ-
ences between groups on the primary outcome measure
ANELT-A [7,19]. The authors conclude that not all
patients with aphasia after stroke benefit from early in-
tensive SLT, but it can be questioned whether therapy in
this study was sufficiently intensive [8-10].
Based on the currently available evidence, we suggest
an optimal regime of early initiated intensive CLT for
aphasia after stroke. This regime will be studied in the
Rotterdam Aphasia Therapy Study (RATS) – 3.Objective
The objective of this study is to test the hypothesis that
patients with aphasia after stroke benefit more from
early initiated intensive cognitive-linguistic therapy than
from deferred regular SLT.Methods
RATS-3 is a multicentre, stratified (for centre of inclu-
sion and severity of aphasia) single-blinded randomised
controlled trial with parallel groups (see Figure 1).
Figure 1 Flow diagram of the RATS-3 study design.
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RATS-3 is coordinated by the Erasmus MC – University
Medical Center Rotterdam, and over 40 hospitals, nurs-
ing homes and rehabilitation centres in The Netherlands
participate. SL-therapists in participating centres are
trained and supervised by the trial team.
Hospitalised patients with aphasia due to stroke are
screened by the local SL-therapist for eligibility with theinclusion and exclusion criteria within two weeks after
stroke (see Table 1).
Written informed consent is acquired by the local SL-
therapist from eligible patients and/or their family. Patient
information and consent forms are approved by the med-
ical ethical committee of the Erasmus MC – University
Medical Center Rotterdam. Local SL-therapists will in-
form the RATS-3 team of every new participant.
Table 1 Eligibility criteria for the Rotterdam Aphasia
Therapy Study (RATS) – 3
Inclusion criteria:
1. Aphasia after stroke, determined by a neurologist or rehabilitation
physician and speech and language therapist;
2. Within two weeks after stroke;
3. Testable with ScreeLing [20];
4. Aphasia ascertained with shortened Token Test [21] and/or a score
<5 on Goodglass Aphasia Severity Rating Scale [22];
5. Age between 18 and 85 years;
6. Language near native Dutch;
7. Life expectancy of more than six months.
Exclusion criteria:
1. Pre-existing aphasia;
2. Subarachnoid/subdural haemorrhage/hematoma;
3. Severe threats to success and/or feasibility of language
therapy:
a. Severe dysarthria;
b. Premorbid dementia;
c. Illiteracy;
d. Severe developmental dyslexia;
e. Severe visual perceptual disorders;
f. Recent psychiatric history.
Table 2 Illustration of CLT with the semantic therapy
program BOX and the phonological program FIKS
Semantic therapy program BOX Subject: word meaning Objective:
consolidate the internal semantic network to improve word finding
Presentation: oral, visual or by computer (eBOX)
Examples:
Word level Sentence level
Which word does not match? Is this sentence correct?
Ruler The balloon flies in the air.
Musical scale Correct.
Gauge
Balance The candle is burning embittered.
Measuring tape Incorrect. Please correct the sentence.
Phonological therapy program FIKS Subject: processing and
production of speech sounds Objective: consolidate the internal
phonological network and improve production of speech, to improve
word finding Presentation: oral, visual or by computer (eFIKS)
Examples:
Word level
Which word is printed here? tion trans la = translation
Read it out loud please. ment ta tes = testament
Sentence level
Please finish the sentence with a
rhyming word:
The enthusiastic amateur cook,
read the recipe carefully in his
cooking- . . .
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All candidates will be tested with the ScreeLing [20], a
screening instrument for aphasia. Aphasia is ascertained
by the shortened version of the Token Test [21] and a
sample of spontaneous speech assessed with the Good-
glass Aphasia Severity Rating Scale [22]. Activities of
daily life will be reported with the Barthel Index [23]
and observational data on social and (neuro)psycho-
logical functioning and wellbeing will be collected with
the MAAS (Multi-axial Aphasia System [24]).
Randomisation
Each participant is assigned to either Group A or Group B
by restricted randomisation via stratification for severity of
aphasia and centre of inclusion. The allocation sequence is
computer generated and concealed in consecutively num-
bered, opaque, sealed envelopes. The trial coordinator ran-
domises participants to treatment groups after severity of
aphasia is assessed. A score on the Goodglass Aphasia Se-
verity Rating Scale [22] of 0 to 2 is considered to reflect
severe aphasia and a score of 3 to 5 reflects moderate to
mild aphasia.
Intervention
As soon as possible after randomisation the intervention
period of four weeks starts, during which Group A
receives early intensive CLT and Group B receives no SLT.
Intervention group: Group A (N = 75)
Participants allocated to Group A receive intensive CLT
with the treatment programs BOX [25] and/or FIKS[26]. The BOX and FIKS programs are commonly used
in The Netherlands and aim at the improvement of word
finding (see Table 2). BOX focuses on semantics and
FIKS on phonology. Both interventions are well outlined,
which ensures homogeneity of treatment in this group
[6]. BOX and FIKS consist of several subparts that pro-
vide a large number of specific exercises, to treat various
layers of semantic and phonological processing. Exer-
cises can be presented visually and/or orally and require
receptive and productive skills. Each subpart contains
different levels of complexity, which makes these pro-
grams suitable to all types and severity levels of aphasia.
Both programs are also available on computer (eBOX
and eFIKS) to facilitate homework.
Therapy will start at the latest two weeks after stroke.
However, as soon as participants are included and ran-
domised, therapy can be started.
Recent findings on intensity of treatment [3,8] suggest
that one hour of language therapy per day is sufficiently
intensive to generate an effect of therapy on top of the
effect of spontaneous recovery. This high intensity is un-
common in The Netherlands. Therefore SL-therapists
will treat participants at least two hours a week, supple-
mented with homework using paper or digital versions
of the therapy programs. The SL-therapists register all
therapy sessions in minutes on special registration
forms. These forms will be handed to the patient and/or
his caretaker also for homework registration.
Table 3 Linguistic test battery of RATS-3
General communication tests
- ANELT-A: communicative functioning in daily life [7];
- Semi-standardised interview for spontaneous speech rated with
Goodglass Aphasia Severity Rating Scale [22];
- Sabadel: connected speech [27];
- ScreeLing: screening of three linguistic components: semantics,
phonology and syntax [28];
- Token Test, short version: measures severity of aphasia [21];
- Boston Naming Test: identifies word finding difficulties [29].
Specific semantic tests
- Semantic Association Test, verbal version (SAT) [30];
- Comprehensive Aphasia Test, word comprehension (CAT) [31];
- Semantic Word Fluency [32].
Specific phonological tests
- Nonword repetition, PALPA [33];
- Auditory Lexical Decision, PALPA [33];
- Letter Fluency [34].
General
- Barthel Index: activities of daily life [23];
- Multi-Axial Aphasia System (MAAS) [24];
- Partner ANELT: partner’s perspective on the patient’s communicative
functioning [35];
- Self evaluation of communicative functioning on a 0 to10 scale;
- EuroQol: quality of life [36];
- Modified Rankin Scale: activities of daily life [37].
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week to check whether the allocated treatment is ad-
equately applied and ask if any problems arise complying
with the protocol.
Control group: Group B (N = 75)
Language therapy is deferred in Group B. Regular language
therapy will start four weeks after randomisation. During
these four weeks no SLT is allowed. SL-therapists, however,
will be attentive to participants in Group B. They may in-
form the patient and his caretakers about aphasia and its
consequences and provide advice to avoid severe communi-
cation distress. Additional diagnostic tests and specific
observations on communicative functioning may be per-
formed to set detailed therapy goals.
Therapy after four weeks by a SL-therapist will be
arranged if the patient is discharged home. The trial co-
ordinator will keep in contact with the patient during
these four weeks. If the patient is released to a rehabili-
tation centre or nursing home, the coordinator will con-
tact the SL-therapist after two weeks to evaluate
whether the protocol can be followed correctly.
Follow-up measurements
Verbal communicative abilities of participants will be evalu-
ated four weeks after randomisation, three months after in-
clusion and six months after inclusion, using an extensive
linguistic test battery (see Table 3). Tests requiring a verbal
response are recorded digitally. All SL-therapists receive a
manual for the administration of the linguistic tests. Results
will be scored in a booklet containing all score forms per
test moment. The trial team will score all tests and report
the results to the SL-therapists.
Aphasia type will be determined with the Aachen
Aphasia Test (AAT, [38]) between the fourweek and
threemonth test. This period after spontaneous recovery
is chosen because we assume aphasia type will then be
stabilised.
Sequel after the four week test
Regular language therapy will start in Group B and
Group A continues with regular therapy after the four-
week test. Regular therapy in The Netherlands comprises
a combination of CLT and communicative therapy and
focuses mainly on therapy goals set by the patient. Regu-
lar therapy intensity is on average approximately two
hours per week [39]. Registration of therapy sessions
and therapy type (either CLT or communicative or a
combination) will be continued, although not as meticu-
lously as during the four weeks of intervention.
Primary outcome
The primary outcome measure in RATS-3 is the differ-
ence in the score on the ANELT-A [7] at the four weektest moment (after intervention) between the two
groups. CLT aims at improving linguistic skills, which
theoretically results in better daily communication. The
A-scale of the valid and reliable ANELT [40] measures
verbal communicative ability. Participants’ verbal
responses to 10 everyday communicative scenarios are
scored on a five-point scale for information content.Secondary outcomes
The difference in scores between groups at the four week
test on the Semantic Association Test (SAT), verbal ver-
sion [30]; Semantic Word Fluency [32], Psycholinguistic
Assessment of Language Processing in Aphasia (PALPA),
Nonword repetition [33]; PALPA, Auditory Lexical Deci-
sion [33]; and Letter Fluency [34] will be used as secondary
outcome measures. Other secondary outcomes are differ-
ences in all test scores at three months, and differences in
scores on the EuroQol (quality of life) [36] and Modified
Rankin Scale (functional outcome) [37].Tertiary outcomes
Scores on the above mentioned tests at six months after
inclusion, including ANELT-A, will be used as tertiary
outcome measures.
Table 4 Provisional list of participating centres and the
principal local investigators*
Hospitals Principal Investigator
Haven Ziekenhuis, Rotterdam Ida Boas
Sint Franciscus Gasthuis, Rotterdam Joyce van Dalen
Ikazia Ziekenhuis, Rotterdam Mathanja Sibon
Maasstad Ziekenhuis, Rotterdam Fabiënne Stok
Vlietland Ziekenhuis, Schiedam Obbe de Roos
IJsselland Ziekenhuis, Capelle aan de IJssel Ingrid Arp
Reinier de Graaf Gasthuis, Delft Jolanda van Veldhuizen
MCH Westeinde, Den Haag Marike Kamphuis,
MCH Antoniushove, Leidschendam Christa Kerkhof
Haga Ziekenhuis, Den Haag Nienke Splinter
VUMC, Amsterdam Antoinette Keulen
Diaconessenhuis, Meppel Cock Meijs
Rivas, Beatrix Ziekenhuis, Gorinchem Wieteke Musterd
Amphia Ziekenhuis, Breda Sylvia Goosen
Rehabilitation centres Principal investigator
Laurens Antonius, Binnenweg, Rotterdam Siri Siepel
Laurens Antonius, IJsselmonde, Rotterdam Ankerien Gerritse
Rijndam, Central clinic, Rotterdam Mieke van de Sandt
Rijndam, Central outpatient centre, Rotterdam Miranda de Waard-van
Rijn
Rijndam, Vlietland outpatient centre, Schiedam Merle Paterson
Rijndam, De Waarden outpatient centre,
Gorinchem
Wieteke Musterd
Vlietland Ziekenhuis outpatient centre,
Schiedam
Obbe de Roos
Centrum voor Reuma en Revalidatie,
Rotterdam
Anke de Meij
Maasstad Ziekenhuis outpatient centre,
Rotterdam
Fabiënne Stok
Zonnehuis, Vlaardingen Suzanne van Almenkerk
Sophia Revalidatie, Delft Marjolein Zomerdijk
Stichting Pieter van Foreest, Delft Margot van
Vorstenbosch
Sophia Revalidatie, Den Haag Elske van Egmond
Florence, Gulden Huis, Den Haag Charlotte Schmitz
Florence, Huize Westhoff, Rijswijk Charlotte Schmitz
Florence, Mariahoeve, Den Haag Charlotte Schmitz
Zonnehuis, Amstelveen Jan van Olsthoorn
Reade, Amsterdam Laurien Sietsma
De Volckaert-SBO, Oosterhout Marianne Slabbekoorn
Stichting Elisabeth, Breda Judith van Bree
Thebe Aeneas, Breda Cirsten van Gelder
De Riethorst-Stromenland, Geertruidenberg Cirsten van Gelder
Stichting Bilthuysen, De Biltse Hof, Bilthoven Melanie Swens
Zorgcombinatie Noorderboog, Reggersoord,
Meppel
Nelleke Loseman
Stichting Groenhuysen, Roosendaal Saskia Aarts
Avoord Zorg en Wonen, Etten-Leur Nancy Schuurman
Table 4 Provisional list of participating centres and the
principal local investigators* (Continued)
Stichting SHDH, Janskliniek, Haarlem Annet Voogd
Stichting Afasietherapie, Amsterdam Marieta Gerarts
Rivas, Waerthove, Sliedrecht Wieteke Musterd
Rivas, Lingesteijn, Leerdam Wieteke Musterd
Rivas, Het Gasthuis, Gorinchem Wieteke Musterd
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A sample of 75 participants in each group, a total of 150
participants, is estimated to provide 84% power to detect a
statistically significant difference on the primary outcome
measure between groups at a 5% two-sided significance
level. An inclusion period of two years is estimated to be
required for recruitment.Blinding
Due to the intervention type, therapy or no therapy, it is
impossible for participants and SL-therapists to be blinded
for intervention. Assessment of the primary outcome, how-
ever, will be blinded. Two experienced independent obser-
vers, who are blinded for treatment allocation and test
moment, will score the primary outcome measure
ANELT-A. The mean score of both independent observers
will be used in the analyses. Interobserver agreement will
be assessed by means of a plot of differences between
scores versus their mean. The mean difference between
observers will be calculated with a 95% confidence interval.Statistical analyses
Difference in score on ANELT-A between groups will be
compared with analysis of covariance (ANCOVA) with a
95% confidence interval, adjusted for baseline severity.
Baseline severity is determined according to the Good-
glass Aphasia Severity Rating Scale [22] in a sample of
spontaneous speech.
This method will also be used for the additional linguis-
tic tests in the secondary and tertiary outcome measures.Ethics
The RATS-3 study protocol is approved by the inde-
pendent medical ethical committee of the Erasmus MC –
University Medical Center Rotterdam (MEC-2005-347),
and registered in the Dutch Trial Register (NTR3271) [41].Trial status
The trial started January 2012. We estimate that inclu-
sion will be finished in January 2014.
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In Table 4, we publish the list of participating centres
updated until August 2012. This list is not final as we
are still actively recruiting centres.
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